An illuminating discussion on how artificial intelligence is reshaping the pharmaceutical landscape — from drug discovery to patient care. Moderated by Khawar Mann, co-founder and CEO of Auxilium Services, the panel brings together Mo Khodadadi Executive of AI at PureHealth, Alex Aliper of Insilico Medicine, and Charlie Regis of HKX Capital. Together, they will explore how AI is advancing personalised medicine, transforming research and development, and redefining the future of healthcare.